Cases & Deals

Purdue Pharma pursues patent infringement suit involving OxyContin(R) against generic drug maker Teva

Clients Purdue Pharma L.P.

Jones Day represents Purdue Pharma L.P., The P.F. Laboratories, Inc., and Purdue Pharmaceuticals L.P. in a Hatch-Waxman Act patent infringement litigation matter relating to Teva Pharmaceuticals USA, Inc.'s attempt to market a generic version of Purdue's controlled-release OxyContin(R) pain relief medication.

Purdue Pharma L.P. et al. v. Teva Pharm. USA, Inc., 1:14-cv-02357 (S.D.N.Y.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.